Trait centric view

1. Trait name:	Conception rate
   Ontology terms:	VT:0010464

   124 genes are associated with this trait, with QTL/association found

   • ABCC9: ATP binding cassette subfamily C member 9
     evidenced by: QTL:176360;
   • ACAP2: ArfGAP with coiled-coil, ankyrin repeat and PH domains 2
     evidenced by: QTL:176319;
   • ACAT2: Acetyl-CoA acetyltransferase 2
     evidenced by: QTL:122378; QTL:57145;
   • ACCSL: 1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like [Bos taurus
     evidenced by: QTL:176431;
   • AFF1: AF4/FMR2 family member 1
     evidenced by: QTL:176316; QTL:176318; QTL:176452; QTL:176453;
   • AKT2: AKT serine/threonine kinase 2
     evidenced by: QTL:176441;
   • AMN1: Antagonist of mitotic exit network 1 homolog
     evidenced by: QTL:176361; QTL:176362;
   • ANKRD17: Ankyrin repeat domain 17
     evidenced by: QTL:176376;
   • AP3B1: Adaptor-related protein complex 3, beta 1 subunit
     evidenced by: QTL:122379; QTL:122408; QTL:57146;
   • ARL6IP1: ADP-ribosylation factor-like 6 interacting protein 1
     evidenced by: QTL:122380; QTL:57137;
   • AXL: AXL receptor tyrosine kinase
     evidenced by: QTL:176442;
   • BCAS1: Breast carcinoma amplified sequence 1
     evidenced by: QTL:57148;
   • BCKDHA: Branched chain keto acid dehydrogenase E1 subunit alpha
     evidenced by: QTL:176443;
   • BOLA-DMB: Major histocompatibility complex, class II, DM beta
     evidenced by: QTL:122381; QTL:122409;
   • BRF1: BRF1, RNA polymerase III transcription initiation factor subunit
     evidenced by: QTL:123998;
   • BRINP3: Bone morphogenetic protein/retinoic acid inducible neural-specific 3
     evidenced by: QTL:122413;
   • BSP3: Binder of sperm 3
     evidenced by: QTL:122382;
   • C1QB: Complement component 1, q subcomponent, B chain
     evidenced by: QTL:57149;
   • C2CD5: C2 calcium dependent domain containing 5
     evidenced by: QTL:176363;
   • C7H19ORF60: Chromosome 7 open reading frame, human C19orf60
     evidenced by: QTL:122383;
   • CACNA1D: Calcium channel, voltage-dependent, L type, alpha 1D subunit
     evidenced by: QTL:122411; QTL:57138;
   • CACNA1H: Calcium channel, voltage-dependent, T type, alpha 1H subunit
     evidenced by: QTL:22580; QTL:22587;
   • CAST: Calpastatin
     evidenced by: QTL:122384; QTL:57150;
   • CCDC86: Coiled-coil domain containing 86
     evidenced by: QTL:57151;
   • CCT8: Chaperonin containing TCP1, subunit 8
     evidenced by: QTL:57152;
   • CD40: CD40 molecule, TNF receptor superfamily member 5
     evidenced by: QTL:122385; QTL:122386;
   • CENPC: Centromere protein C
     evidenced by: QTL:176377; QTL:176378;
   • CEP152: Centrosomal protein 152
     evidenced by: QTL:176422;
   • CHST8: Carbohydrate sulfotransferase 8
     evidenced by: QTL:167558;
   • CKAP5: Cytoskeleton associated protein 5
     evidenced by: QTL:176432;
   • COQ9: Coenzyme Q9
     evidenced by: QTL:122387; QTL:57154;
   • COX17: Cytochrome c oxidase copper chaperone COX17
     evidenced by: QTL:176320;
   • CPSF1: Cleavage and polyadenylation specific factor 1, 160kDa
     evidenced by: QTL:57155;
   • CSPP1: Centrosome and spindle pole associated protein 1
     evidenced by: QTL:57157;
   • CYTH4: Cytohesin 4
     evidenced by: QTL:176364;
   • DCK: Deoxycytidine kinase
     evidenced by: QTL:176379;
   • DEPDC5: DEP domain containing 5
     evidenced by: QTL:176439;
   • DGAT1: Diacylglycerol O-acyltransferase 1
     evidenced by: QTL:11532;
   • DSC2: Desmocollin 2
     evidenced by: QTL:122390;
   • DYNC1I2: Dynein, cytoplasmic 1, intermediate chain 2
     evidenced by: QTL:22584;
   • DZIP3: DAZ interacting zinc finger protein 3
     evidenced by: QTL:122391;
   • ELP4: Elongator acetyltransferase complex subunit 4
     evidenced by: QTL:176433;
   • EPAS1: Endothelial PAS domain protein 1
     evidenced by: QTL:122392;
   • EPHA5: EPH receptor A5
     evidenced by: QTL:176380;
   • EXOC2: Exocyst complex component 2
     evidenced by: QTL:138494;
   • EYA4: EYA transcriptional coactivator and phosphatase 4
     evidenced by: QTL:176405; QTL:176406;
   • FAR2: Fatty acyl-CoA reductase 2
     evidenced by: QTL:176365;
   • FETUB: Fetuin B
     evidenced by: QTL:176321;
   • FGD4: FYVE, RhoGEF and PH domain containing 4
     evidenced by: QTL:176366;
   • FST: Follistatin
     evidenced by: QTL:122393; QTL:122394;
   • FUT1: Fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)
     evidenced by: QTL:122395; QTL:57158;
   • GALK2: Galactokinase 2
     evidenced by: QTL:176423;
   • GC: Group-specific component (vitamin D binding protein)
     evidenced by: QTL:176381; QTL:176382;
   • GCNT3: Glucosaminyl (N-acetyl) transferase 3, mucin type
     evidenced by: QTL:122414;
   • GHR: Growth hormone receptor
     evidenced by: QTL:11544;
   • GOLGA4: Golgin A4
     evidenced by: QTL:122396; QTL:57140;
   • GPLD1: Glycosylphosphatidylinositol specific phospholipase D1
     evidenced by: QTL:57159;
   • HSD17B12: Hydroxysteroid (17-beta) dehydrogenase 12
     evidenced by: QTL:122397; QTL:122398;
   • HSD17B7: Hydroxysteroid (17-beta) dehydrogenase 7
     evidenced by: QTL:122399; QTL:122400; QTL:57160;
   • IBSP: Integrin-binding sialoprotein
     evidenced by: QTL:122401; QTL:122402;
   • IGF2BP2: Insulin like growth factor 2 mRNA binding protein 2
     evidenced by: QTL:176322; QTL:176323; QTL:176324;
   • IL20RA: Interleukin 20 receptor subunit alpha
     evidenced by: QTL:176407;
   • ILDR1: Immunoglobulin like domain containing receptor 1
     evidenced by: QTL:176325; QTL:176326;
   • ITGB5: Integrin subunit beta 5
     evidenced by: QTL:176327;
   • ITPR2: Inositol 1,4,5-trisphosphate receptor, type 2
     evidenced by: QTL:176367; QTL:176368;
   • KALRN: Kalirin RhoGEF kinase
     evidenced by: QTL:176328; QTL:176329; QTL:176330; QTL:176331; QTL:176332; QTL:176333;
   • KAT8: Lysine acetyltransferase 8
     evidenced by: QTL:123997;
   • KCNMB2: Potassium calcium-activated channel subfamily M regulatory beta subunit 2
     evidenced by: QTL:176334;
   • LARGE: Like-glycosyltransferase
     evidenced by: QTL:176369;
   • LDB3: LIM domain binding 3
     evidenced by: QTL:57141; QTL:57161;
   • LOC100140490: Transmembrane protease serine 11C
     evidenced by: QTL:176383;
   • LOC101904601: Uncharacterized LOC101904601
     evidenced by: QTL:176408;
   • LOC104968898: Uncharacterized LOC104968898
     evidenced by: QTL:176384;
   • LOC107133473: Proline-rich protein HaeIII subfamily 1-like
     evidenced by: QTL:176434;
   • LOC521021: Ectonucleotide pyrophosphatase/phosphodiesterase family member 7-like
     evidenced by: QTL:22582; QTL:22589;
   • LOC617302: Testisin-like
     evidenced by: QTL:22581;
   • LOC784935: Histone acetyltransferase p300-like
     evidenced by: QTL:22579; QTL:22585;
   • LSG1: Large 60S subunit nuclear export GTPase 1
     evidenced by: QTL:176336;
   • MAP1B: Microtubule-associated protein 1B
     evidenced by: QTL:30590; QTL:30591; QTL:30592;
   • MARVELD1: MARVEL domain containing 1
     evidenced by: QTL:57162;
   • MCF2L2: MCF.2 cell line derived transforming sequence-like 2
     evidenced by: QTL:176337;
   • MON1B: MON1 secretory trafficking family member B
     evidenced by: QTL:57163;
   • MOXD1: Monooxygenase DBH like 1
     evidenced by: QTL:176409;
   • MRPL48: Mitochondrial ribosomal protein L48
     evidenced by: QTL:122403; QTL:122404;
   • MRPS35: Mitochondrial ribosomal protein S35
     evidenced by: QTL:176370;
   • MS4A8: Membrane-spanning 4-domains, subfamily A, member 8
     evidenced by: QTL:57142;
   • MYEF2: Myelin expression factor 2
     evidenced by: QTL:176424;
   • MYO5A: Myosin VA
     evidenced by: QTL:176425;
   • NCAM2: Neural cell adhesion molecule 2
     evidenced by: QTL:160535;
   • NEU3: Sialidase 3 (membrane sialidase)
     evidenced by: QTL:57164;
   • OCLN: Occludin
     evidenced by: QTL:122405; QTL:57166;
   • PAK2: P21 (RAC1) activated kinase 2
     evidenced by: QTL:176338;
   • PARM1: Prostate androgen-regulated mucin-like protein 1
     evidenced by: QTL:57143; QTL:57167;
   • PCCB: Propionyl CoA carboxylase, beta polypeptide
     evidenced by: QTL:122406;
   • PELI2: Pellino E3 ubiquitin protein ligase family member 2
     evidenced by: QTL:176426;
   • PIWIL3: Piwi like RNA-mediated gene silencing 3
     evidenced by: QTL:138486;
   • PMM2: Phosphomannomutase 2
     evidenced by: QTL:122407; QTL:57168;
   • PPFIBP1: PPFIA binding protein 1
     evidenced by: QTL:176371;
   • PPP1R11: Protein phosphatase 1, regulatory (inhibitor) subunit 11
     evidenced by: QTL:30593;
   • PROP1: PROP paired-like homeobox 1
     evidenced by: QTL:25218;
   • RABEP2: Rabaptin, RAB GTPase binding effector protein 2
     evidenced by: QTL:57169;
   • RABL3: RAB, member of RAS oncogene family like 3
     evidenced by: QTL:258055;
   • RIMS1: Regulating synaptic membrane exocytosis 1
     evidenced by: QTL:123995;
   • ROGDI: Rogdi homolog (Drosophila)
     evidenced by: QTL:22588;
   • ROPN1: Rhophilin associated tail protein 1
     evidenced by: QTL:176339;
   • SEC14L1: SEC14-like 1
     evidenced by: QTL:57170;
   • SIPA1L3: Signal induced proliferation associated 1 like 3
     evidenced by: QTL:176317; QTL:176444;
   • SLC18A2: Solute carrier family 18 (vesicular monoamine transporter), member 2
     evidenced by: QTL:57172;
   • SLC25A48: Solute carrier family 25 member 48
     evidenced by: QTL:176454;
   • SLC4A4: Solute carrier family 4 member 4
     evidenced by: QTL:176385;
   • SPOCK1: SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
     evidenced by: QTL:176455;
   • STAT5A: Signal transducer and activator of transcription 5A
     evidenced by: QTL:30594;
   • TANGO2: Transport and golgi organization 2 homolog (Drosophila)
     evidenced by: QTL:122410;
   • TBC1D24: TBC1 domain family, member 24
     evidenced by: QTL:57173;
   • TDRKH: Tudor and KH domain containing
     evidenced by: QTL:57144; QTL:57174;
   • TMTC1: Transmembrane O-mannosyltransferase targeting cadherins 1
     evidenced by: QTL:176372;
   • TSPAN4: Tetraspanin 4
     evidenced by: QTL:176459;
   • UBXN7: UBX domain protein 7
     evidenced by: QTL:176340;
   • UGT2A1: UDP glucuronosyltransferase family 2 member A1 complex locus
     evidenced by: QTL:176386;
   • WBP1: WW domain binding protein 1
     evidenced by: QTL:57175;
   • ZBTB20: Zinc finger and BTB domain containing 20
     evidenced by: QTL:176341; QTL:176342;
   • ZNF541: Zinc finger protein 541
     evidenced by: QTL:22586;
   • ZNF574: Zinc finger protein 574
     evidenced by: QTL:176445;
   • ZP2: Zona pellucida glycoprotein 2
     evidenced by: QTL:57176;
   177 correlations are found involving Conception rate
    

2. Trait name:	First service conception
   Ontology terms:	VT:0010464

   102 genes are associated with this trait, with QTL/association found

   • ACER1: Alkaline ceramidase 1
     evidenced by: QTL:212168;
   • ADGRE3: Adhesion G protein-coupled receptor E3
     evidenced by: QTL:212165;
   • AGPAT4: 1-acylglycerol-3-phosphate O-acyltransferase 4
     evidenced by: QTL:212218;
   • AKTIP: AKT interacting protein
     evidenced by: QTL:212322;
   • ASB18: Ankyrin repeat and SOCS box containing 18
     evidenced by: QTL:212121;
   • ATF6: Activating transcription factor 6
     evidenced by: QTL:212106;
   • CAMK2D: Calcium/calmodulin dependent protein kinase II delta
     evidenced by: QTL:212151;
   • CCDC171: Coiled-coil domain containing 171
     evidenced by: QTL:212186;
   • CD109: CD109 molecule
     evidenced by: QTL:212198;
   • CDH23: Cadherin related 23
     evidenced by: QTL:212394;
   • CEP128: Centrosomal protein 128
     evidenced by: QTL:212235;
   • CHD9: Chromodomain helicase DNA binding protein 9
     evidenced by: QTL:212321;
   • CHI3L2: Chitinase 3 like 2
     evidenced by: QTL:212109;
   • CHMP4A: Charged multivesicular body protein 4A
     evidenced by: QTL:212226;
   • CIT: Citron rho-interacting serine/threonine kinase
     evidenced by: QTL:212315; QTL:212316;
   • CLASP2: Cytoplasmic linker associated protein 2
     evidenced by: QTL:212351;
   • DCP1A: Decapping mRNA 1A
     evidenced by: QTL:212357;
   • DDX55: DEAD-box helicase 55
     evidenced by: QTL:212313;
   • DERA: Deoxyribose-phosphate aldolase
     evidenced by: QTL:212145;
   • DHX57: DEAH (Asp-Glu-Ala-Asp/His) box polypeptide 57
     evidenced by: QTL:212239;
   • DHX9: DExH-box helicase 9
     evidenced by: QTL:212304;
   • DIP2B: Disco interacting protein 2 homolog B
     evidenced by: QTL:212136;
   • DNMBP: Dynamin binding protein
     evidenced by: QTL:212382;
   • EFCAB3: EF-hand calcium binding domain 3
     evidenced by: QTL:212329;
   • ELP4: Elongator acetyltransferase complex subunit 4
     evidenced by: QTL:212293;
   • EPB41L5: Erythrocyte membrane protein band 4.1 like 5
     evidenced by: QTL:212099;
   • EXOC6B: Exocyst complex component 6B
     evidenced by: QTL:212238;
   • FAHD2A: Fumarylacetoacetate hydrolase domain containing 2A
     evidenced by: QTL:212237;
   • FNIP2: Folliculin interacting protein 2
     evidenced by: QTL:212311;
   • GADD45GIP1: GADD45G interacting protein 1
     evidenced by: QTL:212166;
   • GBX1: Gastrulation brain homeobox 1
     evidenced by: QTL:212130;
   • GMPR: Guanosine monophosphate reductase
     evidenced by: QTL:212363;
   • GRIA4: Glutamate ionotropic receptor AMPA type subunit 4
     evidenced by: QTL:212287;
   • HIP1: Huntingtin interacting protein 1
     evidenced by: QTL:212376;
   • IQGAP1: IQ motif containing GTPase activating protein 1
     evidenced by: QTL:212346;
   • IVNS1ABP: Influenza virus NS1A binding protein
     evidenced by: QTL:212305;
   • KCNIP4: Kv channel interacting protein 4
     evidenced by: QTL:212152;
   • KCNN2: Potassium calcium-activated channel subfamily N member 2
     evidenced by: QTL:212223;
   • KLHL1: Kelch like family member 1
     evidenced by: QTL:212263;
   • KPNA3: Karyopherin subunit alpha 3
     evidenced by: QTL:212258;
   • KPNA6: Karyopherin subunit alpha 6
     evidenced by: QTL:212090;
   • LPIN2: Lipin 2
     evidenced by: QTL:212369;
   • LRBA: LPS responsive beige-like anchor protein
     evidenced by: QTL:212308;
   • MAP3K3: Mitogen-activated protein kinase kinase kinase 3
     evidenced by: QTL:212330;
   • MAP6: Microtubule associated protein 6
     evidenced by: QTL:212291;
   • MAPKAP1: Mitogen-activated protein kinase associated protein 1
     evidenced by: QTL:212253;
   • MARCHF11: Membrane associated ring-CH-type finger 11
     evidenced by: QTL:212337;
   • MARCHF3: Membrane associated ring-CH-type finger 3
     evidenced by: QTL:212169;
   • MOG: Myelin oligodendrocyte glycoprotein
     evidenced by: QTL:212359;
   • MTMR7: Myotubularin related protein 7
     evidenced by: QTL:212388;
   • MUC19: Mucin 19, oligomeric
     evidenced by: QTL:212138;
   • MYO10: Myosin X
     evidenced by: QTL:212336;
   • MYO16: Myosin XVI
     evidenced by: QTL:212267;
   • NBAS: NBAS subunit of NRZ tethering complex
     evidenced by: QTL:212249;
   • NLGN4X: Neuroligin 4 X-linked
     evidenced by: QTL:212415;
   • NOL4: Nucleolar protein 4
     evidenced by: QTL:212367;
   • NTRK2: Neurotrophic receptor tyrosine kinase 2
     evidenced by: QTL:212192;
   • PAFAH1B1: Platelet activating factor acetylhydrolase 1b regulatory subunit 1
     evidenced by: QTL:212327;
   • PAICS: Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase
     evidenced by: QTL:212154;
   • PARN: Poly(A)-specific ribonuclease
     evidenced by: QTL:212375;
   • PCED1B: PC-esterase domain containing 1B
     evidenced by: QTL:212137;
   • PDCD4: Programmed cell death 4
     evidenced by: QTL:212384;
   • PDE10A: Phosphodiesterase 10A
     evidenced by: QTL:212221;
   • PGAP1: Post-GPI attachment to proteins inositol deacylase 1
     evidenced by: QTL:212102;
   • PITRM1: Pitrilysin metallopeptidase 1
     evidenced by: QTL:212273;
   • PKHD1: PKHD1, fibrocystin/polyductin
     evidenced by: QTL:212358;
   • PKIA: Protein kinase (cAMP-dependent, catalytic) inhibitor alpha
     evidenced by: QTL:212283;
   • PLA2G12B: Phospholipase A2 group XIIB
     evidenced by: QTL:212395;
   • PLA2R1: Phospholipase A2 receptor 1
     evidenced by: QTL:212097;
   • PLCB1: Phospholipase C beta 1
     evidenced by: QTL:212268;
   • PLSCR5: Phospholipid scramblase family member 5
     evidenced by: QTL:212087;
   • POLD3: DNA polymerase delta 3, accessory subunit
     evidenced by: QTL:212290;
   • PRKG1: Protein kinase, cGMP-dependent, type I
     evidenced by: QTL:212380;
   • PTPRD: Protein tyrosine phosphatase receptor type D
     evidenced by: QTL:213029;
   • QKI: QKI, KH domain containing RNA binding
     evidenced by: QTL:212219;
   • RABGAP1: RAB GTPase activating protein 1
     evidenced by: QTL:212252;
   • RECQL5: RecQ helicase-like 5
     evidenced by: QTL:212331;
   • RESTB: RE1 silencing transcription factor B
     evidenced by: QTL:212155;
   • RNF17: Ring finger protein 17
     evidenced by: QTL:212261;
   • RPE65: Retinoid isomerohydrolase RPE65
     evidenced by: QTL:212116;
   • SEMA4A: Semaphorin 4A
     evidenced by: QTL:212108;
   • SGCD: Sarcoglycan delta
     evidenced by: QTL:212176;
   • SIN3B: SIN3 transcription regulator family member B
     evidenced by: QTL:212164;
   • SLAIN2: SLAIN motif family member 2
     evidenced by: QTL:212153;
   • SLC9A9: Solute carrier family 9 member A9
     evidenced by: QTL:212089;
   • SPATA16: Spermatogenesis associated 16
     evidenced by: QTL:212083;
   • STAP1: Signal transducing adaptor family member 1
     evidenced by: QTL:212159;
   • SV2C: Synaptic vesicle glycoprotein 2C
     evidenced by: QTL:212224;
   • SYNE1: Spectrin repeat containing nuclear envelope protein 1
     evidenced by: QTL:212215;
   • TASOR: Transcription activation suppressor
     evidenced by: QTL:212356;
   • TESK2: Testis associated actin remodelling kinase 2
     evidenced by: QTL:212120;
   • TIAM1: TIAM Rac1 associated GEF 1
     evidenced by: QTL:212069;
   • TOX3: TOX high mobility group box family member 3
     evidenced by: QTL:212320;
   • TRPM7: Transient receptor potential cation channel subfamily M member 7
     evidenced by: QTL:212230;
   • TSGA10IP: Testis specific 10 interacting protein
     evidenced by: QTL:212403;
   • UBR1: Ubiquitin protein ligase E3 component n-recognin 1
     evidenced by: QTL:212228;
   • UPK1B: Uroplakin 1B
     evidenced by: QTL:212079;
   • USH2A: Usherin
     evidenced by: QTL:212300;
   • UTRN: Utrophin
     evidenced by: QTL:212214;
   • VTI1A: Vesicle transport through interaction with t-SNAREs 1A
     evidenced by: QTL:212385;
   • VWC2: Von Willebrand factor C domain containing 2
     evidenced by: QTL:212122;
   • WWOX: WW domain containing oxidoreductase
     evidenced by: QTL:212319;
   20 correlations are found involving First service conception